Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions

Asthma; Eosinophilic

Interventions

BIOLOGICAL

Dupilumab

600 mg (two 300 mg injections), followed by 300 mg monthly

Trial Locations (1)

RECRUITING

Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90., Barcelona

All Listed Sponsors

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER